A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese

1The prevalence of obesity is rapidly rising worldwide over the past decades. Since obesity increases the risk for diabetes, cardiovascular disease and cancer, it becomes a major health problem and enormously increases the global health burden and health-care cost.

2Obesity is usually assessed by body mass index (BMI) calculated as weight in kilograms divided by height in meter squared, which is well associated with type 2 diabetes, dyslipidemia and cardiovascular diseases. However, BMI does not take into account the heterogeneity of body fat deposition while used as a parameter for body fat excess, and fails to indentify the subgroups of metabolically healthy obese (MHO) and metabolically unhealthy normal weight (MUNW) individuals in general population. Enormous evidence demonstrates that visceral adipose tissue (VAT) rather than subcutaneous adipose tissue plays a vicious role in metabolic diseases. Waist circumference is a simple parameter for abdominal adiposity and better reflects visceral obesity than BMI, but waist circumference alone has limitations in distinguishing between subcutaneous and visceral fat mass. Computed tomography (CT) and magnetic resonance imaging (MRI) allow quantitative measurement of VAT, but they are costly and not routinely carried out in general clinical practice.

3Recently, a clinical visceral adiposity index (VAI), based on waist circumference, BMI, serum triglycerides (TG), and high-density lipoprotein (HDL) cholesterol levels, was established to estimate the visceral adiposity. VAI was significantly correlated with a series of metabolic diseases, including cardiovascular and cerebrovascular disease, non-alcoholic fatty liver disease/NASH, polycystic ovary syndrome, and acromegaly in Caucasians. However, the pronounced differences in body fat distribution existed among various ethnicity. Asian population is characterized by relatively higher body fat content at lower BMI values as compared with Caucasians, and seems to be more prone to visceral fat accumulation. A VAI for estimation of visceral fat area in Asians is definitely indispensable. In the present study, we developed and further externally validated a non-invasive clinical index to estimate visceral fat area in Chinese, the largest Asian ethnic group. We investigated the performance of Chinese visceral adiposity index (CVAI) in prediction of the risk for metabolic syndrome and type 2 diabetes compared with BMI and waist circumference in Chinese population.

4To develop an index to estimate the visceral fat volume, 485 adult subjects were recruited from Lianqian Community, Xiamen, including 133 men and 352 women. The clinical characteristics of the subjects receiving CT examination for visceral fat area were shown in Supplementary Table 1. Univariate correlation analyses showed that visceral fat area was significantly associated with the parameters used in visceral adiposity index (VAI), including BMI (r = 0.49, P < 0.001), waist circumference (r = 0.56, P < 0.001), HDL cholesterol(r = −0.38, P < 0.001), and TG(r = 0.49, P < 0.001). In the setting of the Chinese visceral adiposity index (CVAI), we included the variables which are significantly associated with visceral fat area by univariate analysis. BMI, WC, serum triglyceride and HDL-C, age, smoking, alcohol drinking, serum LDL-C and total cholesterol, blood pressure, and fasting blood glucose were entered in the multivariate regression model. The combination of BMI, WC, triglyceride and HDL-c well constructed the Chinese visceral adiposity index by R2 of 0.40. Further inclusion of age increases R2 by 0.1 for female and 0.01 for male in the model, and greatly improves the model fit. While smoking, alcohol drinking, serum LDL-C, total cholesterol, blood pressure, or glucose levels only increase R2 by less than 0.01 and do not improve model fit significantly. Therefore, the CVAI for visceral adiposity area is estimated as follows:

5Males: CVAI = −267.93 + 0.68 * age + 0.03 * BMI + 4.00 * WC + 22.00 * Log10TG − 16.32 * HDL-C

6Females: CVAI = −187.32 + 1.71 * age + 4.23 * BMI + 1.12 * WC + 39.76 * Log10TG − 11.66 * HDL-C

7As shown in Fig. 1, CVAI was strongly and positively associated with visceral fat area (r = 0.68, P < 0.0001). The area under the ROC curve (AUROC) of CVAI for visceral obesity was 0.83(0.79–0.86) (Fig. 1), which was significantly higher than waist circumference, BMI and VAI established in Italians (AUROC: 0.69–0.76, P < 0.001) (Table 1).

8The CVAI was further validated in 6495 subjects (2761 males and 3734 females) from Shanghai Changfeng community. The clinical characteristics of the subjects were shown in Table 2 according to the quartiles of CVAI. As shown in Table 2, subjects with higher CVAI presented with more obese, and higher waist circumference, fasting blood glucose, blood pressure, liver enzymes and unfavourable lipid profiles (All P < 0.001). A higher proportion of cigarette smokers and alcohol drinkers was found in subjects with high CVAI. Linear correlation analysis showed that CVAI was significantly associated HOMA-IR (r = 0.602, P < 0.001) (Fig. 2).

9The AUROCs of CVAI for diagnosis of metabolic syndrome, hypertension, type 2 diabetes and prediabetes were 0.89(0.88–0.90), 0.72(0.71–0.73), 0.70(0.69–0.71) and 0.67(0.65–0.68), respectively, which is better performed than BMI, waist circumference and VAI (All P < 0.001) (Fig. 3). In the subgroup of 4871 Chinese subjects with lower visceral adiposity (CVAI at Q1-Q3 range) and an average BMI of 23 kg/m2, the AUROCs of CVAI for diagnosis of metabolic syndrome, hypertension, type 2 diabetes and prediabetes were 0.85(0.83–0.86), 0.68(0.67–0.69), 0.66(0.64–0.67) and 0.63(0.62–0.65), respectively (Supplementary Figure 1). Thus, the diagnostic performance of CVAI is similar in Chinese subjects with higher or lower BMI.

10In subjects with MUNW and MHO/overweight, the AUROCs of CVAI were 0.79(0.76–0.82) and 0.77(0.74–0.80), respectively for diagnosing metabolic syndrome, and 0.63(0.59–0.67) and 0.62(0.59–0.65) for diabetes and prediabetes, respectively as compared with BMI and WC (AUROCs 0.61–0.74 for metabolic syndrome and 0.51–0.57 for diabetes/prediabetes) (Fig. 4).

11In the present study, we developed a clinical index, CVAI to predict visceral adipose area in Chinese adults, which could help clinicians to screen for metabolically unhealthy individuals. CVAI is well correlated with insulin resistance and better to predict metabolic syndrome, hypertension and diabetes, particularly in MUNW and MHO subjects compared to BMI and waist circumference.

12It is well known that visceral obesity plays a vicious role in insulin resistance and metabolic syndrome, a cluster of metabolic disorders, including hyperglycemia, hypertension and dyslipidemia. However, it is difficult to quantitate visceral adipose tissues using CT or MRI in large cohort studies. CVAI, a simple clinical index composed of some major parameters of metabolic syndrome, can be used to reflect visceral fat mass. A previous study showed that visceral adiposity index (VAI) could be used as an indicator of visceral adiposity and adipose tissue dysfunction to predict the risk for cardiovascular diseases, insulin resistance and metabolic syndrome in Caucasians. However, VAI was poorly associated with adipose tissue area in Chinese (AUROC: 0.69[0.65–0.73], P < 0.001), possibly due to the remarkable differences in adipose tissue distribution between Caucacians and Asians. Asians could be more prone to have visceral adipose accumulation. Therefore, ethnic difference should be considered while visceral adipose area is evaluated by a clinical index.

13Obesity is a heterogeneous morbidity. Epidemiology studies showed that MUNW and MHO individuals accounted for a non-negligible proportion of the whole population, with an estimated prevalence ranging from 10–37% in lean and 13–29% in obese individuals. In MUNW and MHO subjects, BMI can lead to miscalculation of individual metabolic risks. Waist circumference, correlated with central obesity, is better to predict obesity-related metabolic abnormalities than BMI. However, waist circumference is still inaccurate to distinct subcutaneous adipose tissue from the visceral fat, and has poor diagnostic performance to predict prediabetes and diabetes in MUNW and MHO subjects, as shown in Fig. 4. The new index CVAI demonstrated the best performance for prediction of prediabetes and diabetes in MUNW and MHO individuals, and in whole population in our current study.

14One major limitation of the current study is that the prediction value of CVAI is validated by assessing its correlation with HOMA-IR, a parameters of visceral fat function, but not directly with visceral fat areas in the validation population from Shanghai Changfeng community. Therefore, further validation of CVAI with imaging visceral fat areas in a second Chinese cohort is still needed.

15In conclusion, CVAI is well correlated with visceral fat mass in Chinese adults. CVAI demonstrates a better prediction than BMI and waist circumference for metabolic disorders.

16485 subjects (133 men and 352 women) with waist circumference greater than 90 cm for men and 85 cm for women were recruited from Lianqian Community, Xiamen to develop an index to estimate the visceral fat volume in Chinese. The detailed information about the subjects was described previously, and their clinical characteristics were shown in Supplementary Table 1. All the 485 subjects received abdominal computed tomography (CT). To further validate the visceral fat index in Chinese, 6495 subjects (2761 men and 3734 women) were recruited from Changfeng Community, Shanghai.

17This study was approved by the Ethical Committee of the First Xiamen Hospital and the Ethical Committee of Zhongshan Hospital Fudan University, respectively. Each participant provided written informed consent. The described methods were carried out in accordance with the guidelines of the Declaration of Helsinki.

18Visceral fat area and subcutaneous area were measured using CT (GE Medical Systems, Milwaukee, WI, USA) at the level of fourth lumbar vertebra. Tissue compartments were measured by planimetry with a trackball-controlled cursor. The area of adipose tissue in each compartment was quantified by the program provided by the manufacture, which sums the areas of the pixels with CT values from −250 to −50 Hounsfield Units that is corresponsive to adipose tissue. Fat area was calculated by FatScan version 2.0 software (N2 System Co., Osaka, Japan). The coefficient of variation for intra-observers was <6.1% and for inter-observers was <6.6% in our current study.

19All participants completed a uniform questionnaire detailing history of diabetes, medication use, smoking status, and alcohol consumption. Body height and weight were measured without shoes and outer clothing. BMI was calculated according to weight in kilograms divided by square of height in meters. Waist circumference was measured using a soft tape at midway between the lowest rib and iliac crest in standing position. All blood samples were obtained after at least 12 h of fasting. Serum total cholesterol, HDL-cholesterol, triglyceride(TG) were measured using oxidase method. LDL cholesterol was calculated using the Friedewald equation. Liver enzymes (ALT, AST) were measured by Ultraviolet (UV) lactate and malate dehydrogenase methods on a model 7600 automated bio-analyser (Hitachi, Tokyo, Japan). Plasma glucose concentrations were measured using glucose oxidase method. Serum insulin concentrations were determined using an electrochemiluminescence immunoassay.

20Subjects with visceral fat area ≥ 100 cm2 were defined as visceral obesity. According to 2006 World Health Organization (WHO), The criteria for metabolic syndrome were central obesity (waist circumference ≥ 90 cm for males and ≥80 cm for females) plus two or more of the following: antihypertensive treatment or blood pressure ≥130/85 mmHg, antidiabetic treatment or fasting blood glucose ≥5.6 mmol/L, triglycerides ≥1.7 mmol/L and HDL cholesterol <1.03 mmol/L for males and <1.29 mmol/L for females. Diabetes mellitus was defined as fasting plasma glucose levels ≥7.0 mmol/L, or a 2-h post-load plasma glucose levels ≥11.1 mmol/L, or taking antidiabetic medications or insulin injection, and prediabetes was diagnosed as fasting plasma glucose 6.1–7.0 mmol/L or post-load plasma glucose 7.8–11.1 mmol/L, according to 1999 WHO criteria. HOMA- IR is calculated by dividing the product of fasting plasma glucose (mmol/L) and fasting plasma insulin (mU/L) by 22.5. Metabolic health status was defined based on insulin resistance level, and HOMA-IR ≥ 2.5 was used as the cut-off value for insulin resistance in accordance with previous studies. Thus, all the individuals were divided into four categories according to BMI (normal body weight: <25 kg/m2; obese/overweight: >25 kg/m2) and estimated insulin resistance level (metabolic health: insulin sensitive and HOMA-IR < 2.5; metabolic unhealth: insulin resistance and HOMA-IR ≥ 2.5). Visceral adiposity index (VAI) was calculated using the equation established in Caucasians previously.

21All statistical analyses were performed using SPSS software version 15.0 (SPSS, Chicago, IL). The data were presented as mean ± SD, except for skewed variables, which were presented as the median with interquartile range (25–75%) given in parentheses. One-way analysis of variance or the Mann-Whitney U-test was used for comparisons of continuous data among groups, whereas the Chi-squared test was used for comparisons of categorical variables. Multivariate linear regression analysis was performed to establish Chinese predictive score (CVAI) for visceral fat dysfunction with candidate variables including age, BMI, waist circumference, TG, and HDL cholesterol, using visceral fat area measured by CT as reference. Receiver operating characteristic (ROC) curve analyses were used to compare the diagnostic performance of CVAI with BMI and waist circumference for risk of metabolic syndrome, and diabetes. Values of P < 0.05 were considered statistically significant for all analyses.

22How to cite this article: Xia, M.-F. et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Sci. Rep. 6, 38214; doi: 10.1038/srep38214 (2016).

23Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.